G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 32,583 | 25,881 | 26,086 | 20,822 | 21,653 |
| Operating Income | -32,583 | -25,881 | -26,086 | -20,822 | -21,653 |
| Other Income | 1,893 | 1,929 | 1,994 | 904 | 785 |
| Pre-tax Income | -30,690 | -23,952 | -24,092 | -19,918 | -20,868 |
| Net Income Continuous | -30,690 | -23,952 | -24,092 | -19,918 | -20,868 |
| Net Income | $-30,690 | $-23,952 | $-24,092 | $-19,918 | $-20,868 |
| EPS Basic Total Ops | -0.82 | -0.64 | -0.63 | -0.59 | -0.64 |
| EPS Basic Continuous Ops | -0.82 | -0.64 | -0.64 | -0.59 | -0.64 |
| EPS Diluted Total Ops | -0.82 | -0.64 | -0.63 | -0.59 | -0.64 |
| EPS Diluted Continuous Ops | -0.82 | -0.64 | -0.64 | -0.59 | -0.64 |
| EBITDA(a) | $-32,518 | $-25,817 | $-26,026 | $-20,774 | $-21,618 |